In Chicago, Jeffrey Hubbell, a Professor of Molecular Engineering Innovation and Enterprise at the University of Chicago, received the Society for Biomaterials’ 2017 Founders Award. Hubbell’s immunotherapy work focuses on designing biomaterials for stimulating the immune system, fighting infections, and even shutting off some autoimmune responses that cause diseases like Type 1 diabetes. Hubbell has co-founded five companies including ClostraBio, a food allergy treatment startup, Kuros Biosciences, a developer of biomaterials technology for surgical sealants, QGel, a developer of biomaterials for cell cultures, Anokion, a developer of autoimmune technology, and Kanyos Bio, a tech developer for Type 1 diabetes and celiac disease. The award is given every year to someone who, according to the University of Chicago, has made “long-term, landmark contributions to the discipline of biomaterials.”
Home Biomaterials Society for Biomaterials Awards 2017 Founders Award to University of Chicago Professor
Latest article
Absolut Vodka inks new partnership in biodegradable bottle pursuit
In Sweden, Absolut Vodka has inked a new partnership with start-up Blue Ocean Closures to increase the use of biodegradable materials in its packaging....
“Magic” mushrooms take centerstage at Glastonbury music festival
In the United Kingdom, acoustic panels made from hemp and mycelium were used in the ceiling of a dance music tent at the recent ...
Beverage company and designer create Dirt Shoe that disintegrates in minutes
In New York, beverage company Yerba Madre and design studio Basura have partnered to create shoes out of dirt, organic fibers, and acacia gum...